|
Alemtuzumab
|
Visite: 226
|
|
Altretamine
|
Visite: 430
|
|
Aminoglutetimide
|
Visite: 398
|
|
L'Acido 5-Aminolevulinico
|
Visite: 335
|
|
Idrossicarbamide
|
Visite: 237
|
|
Anastrozole
|
Visite: 405
|
|
Arsenico Triossido Di
|
Visite: 401
|
|
Asparaginasi
|
Visite: 357
|
|
Bevacizumab
|
Visite: 270
|
|
Bexarotene
|
Visite: 412
|
|
Bleomicina
|
Visite: 395
|
|
Busulfan
|
Visite: 363
|
|
Capecitabina
|
Visite: 371
|
|
Carboplatino
|
Visite: 428
|
|
Carmustina
|
Visite: 422
|
|
Cetuximab
|
Visite: 277
|
|
Ciclofosfamide
|
Visite: 390
|
|
Cisplatino
|
Visite: 266
|
|
La citarabina
|
Visite: 256
|
|
Cladribina
|
Visite: 261
|
|
Chlorambucil
|
Visite: 401
|
|
Chlormethinum
|
Visite: 532
|
|
Dacarbazina
|
Visite: 214
|
|
Dactinomicina
|
Visite: 276
|
|
Daunorubicina
|
Visite: 225
|
|
Docetaxel
|
Visite: 212
|
|
Doxorubicina
|
Visite: 438
|
|
Epirubucin
|
Visite: 222
|
|
Erlotinib
|
Visite: 344
|
|
Etoposide
|
Visite: 272
|
|
Exemestano
|
Visite: 417
|
|
Fluorouracile Topico Soluzione
|
Visite: 198
|
|
Fluorouracile
|
Visite: 272
|
|
Gemcitabina
|
Visite: 206
|
|
Idarubicina-Hcl
|
Visite: 368
|
|
Ifosfamide
|
Visite: 233
|
|
Melfalan
|
Visite: 206
|
|
Mercaptopurina
|
Visite: 351
|
|
Methotrexate
|
Visite: 312
|
|
Mitomicina
|
Visite: 311
|
|
Mitoxantrone
|
Visite: 195
|
|
Oxaliplatino
|
Visite: 187
|
|
Paclitaxel
|
Visite: 250
|
|
Pentostatina
|
Visite: 249
|
|
Procarbazina
|
Visite: 241
|
|
Rituximab
|
Visite: 278
|
|
Teniposide
|
Visite: 206
|
|
Tioguanina
|
Visite: 188
|
|
Tiotepa
|
Visite: 201
|
|
Trastuzumab
|
Visite: 257
|
|
Tretinoin Orale
|
Visite: 387
|
|
Vinblastina
|
Visite: 212
|
|
Vincristina
|
Visite: 203
|
|
Vinorelbine Tartrate
|
Visite: 236
|
|
Everolimus
|
Visite: 236
|
|
Imatinib Mesilato
|
Visite: 226
|
|
Nilotinib
|
Visite: 270
|
|
Dasatinib
|
Visite: 229
|
|
Pazopanib
|
Visite: 202
|
|
Ipilimumab
|
Visite: 202
|
|
Nivolumab
|
Visite: 238
|
|
Brentuximab Vedotin
|
Visite: 232
|